Kidney Transplant ISS Flashcards
need for one or more hd within 1st week
DGF -FUNCAO TARDIA DO ENXERTO
moderate early graft dysfunction, plasma crea > 3 at 1 week post kt
• Allograft function: If a new transplant, is there
immediate graft functioncreat <2,5 dentro de 5 dias
or SGF (Slow graft function) creat >2,5 ate o 5 dia
versus
DGF (Delayed Graft Function, means requiring HD in less than 1 weeks), this is impacted by donor factors, cold ischemia time (>24 hrs), intra-op issues, and patient issues including ischemiareperfusion (warm ischemia time > 45 min).
rejection occuring 2-5 days after transplant
Accelerated rejection
important risk factor for dgf c
cold ischemia time
fatores de risco =
DOADOR= idade, vivo ou falecido, doador padrao, criterio expandido
RECEPTOR= homem, imc>30, negro, dialise, diabetes, HLA imunizacao
tx=tempo de isquemia quente, tempo de isquemia frio, solucao de armazenamento,maquina de perfusoa ou n
high risk patients with rejection symptoms
biopsy day 3-5
low risk patients
biopsy day 7-10
Tx of acute abmr
pulse, plasmapharesis, ivig, rituximab
Mild/moderate tcmr
Steroid pulse
Severe tcmr mgt
steroid pulse:thymoglobuling
high cni levels
Cyclosporine > 350
tacrolimus > 15
common adverse effect of mmf and tacrolimus
diarrhea
renal artery or vein thrombosis occurs in the
1st 72h-10 weeks
most common cause of allograft function in the first week
acute vascular thrombosis
abrupt onset of anuria, rapidly rising crea, negligible graft pain, absent arterial and venous blood flow, MR absent perfusion
renal artery thrombosis
anuria pain tenderness swelling hematuria, absent renal venous blood flow and highly abnormal renal arterial waveforms, mr thrombus in the vein
renal vein thrombosis
failure of impvt in urine output or plasma crea within 5 days of pulse
steroid resistant tcmr
tx depleting antibodies
tcmr resistant to tx witg antilymphocytic antibody
refractory tcell mediated rejection
standard target levels of cyclosporine
C0 150-300, 100-200
C2 1400-1700, 800-1299
standard level tacrolimus
C0 8-12, 6-9
initial measure in transplant tma
switch cni
dc cni, start belatacept or mtor
pex
eculizumab
most common microorganism acute pyelo post kt
Gram neg, cons, enterococci
most common dryg causing ain
smx tmp
best radiologic technique for determining site of obstruction
percutaneous antegrade pyelography
Drugs that increase cni level
ccb
antifungal
antidepressant
grapefruit
decrease cni level
nafcillin
tb meds
efvires nevirapine
antiseizure meds
st johns
plasma viral titers of bk nephropathy
> 10^4
tx of bk
discontinue mmf
redcue cni by 30-50
chronic active abmr tx
switch to tacro-mmf
target tacro 8
minim mmf
low dose pred
ace/arv
striped cortical fibrosis or new onset arteriolar hyalinosis with microcalcification
cni toxicity
Gout post kt
cyclosporine
tx colchicine and steroids
post kt electrolyte do
hyperCa
hypophos
hyperK
met acid
hypoMg
hyperparathyroid
osteoporosis bone density greater than
2.5SD below the mean
osteopenia 1-2.5
antihtn agrnts in transplant
chf, post mi, cad
bblocker and ace/arb
no bblocker in htn and proteinuria only
high intensity statin recommended for > 21 with
ascvd
ldl > 190
persons 40-75 with dn and est 10 yr risk > 7.5
no increased risk ca
breast prostate rectum
high sir ca
kaposi with hiv
poor prognosis ptld
monoclonal
considerations in kt in hiv
cd4 txell > 200
undetectable hiv rna
Pregnancy considerations post kt
good health more than 18 mos
stable allograft function
crea less than 2
minimal htn and proteinuria
indications for allograft nephrectomy
- allograft failure symptomatic
- infarction due to thrombosis
- severe infection
- allograft rupture
Relative contraindication to donation
2 apol1 renal risk variants
chronic illness
type 2 dm
morbid obesity
active substance use disorder
dados importantes sobre o doador
Relevant donor data: age, sex, size, KDPI score, initial/peak/terminal creatinine, HIV/Hep C status urine output, biopsy, relevant history (DM/HTN) Cold and warm ischemia time (preferred cold ischemia time (CIT) is <24 hours and warm ischemia time (WIT) is <45 minutes) Public Health Service (PHS) high risk: yes or no (risk factors include prisoner, history of drug use, sex worker, etc) CMV and EBV status of donor and recipient HLA cross match and if Donor Specific Antibody (DSA) was present Induction therapy Removal of ureteral stent and dialysis catheter (usually to be scheduled post-op so if no date can put to be scheduled) Relevant surgical details if there were intra-operative complications
transplante duplo figado e rim
ira por mais de 6 semas com mais um criterio
- dialise
- tfg<25
tfg<60 por mais de 90 dias com : eskd, tfg<30
doenca metabolica